BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
BioSig Technologies (NASDAQ:BSGM) announced a corporate rebranding to Streamex Corp., effective September 12, 2025, following its recent merger with Streamex Exchange Corporation. The company will begin trading under the new ticker symbol "STEX" on the Nasdaq Capital Market exchange.
The rebranding reflects the company's expanded business model and growth strategy. Shareholders are not required to take any action as the CUSIP number remains unchanged, and the corporate structure and operations will continue as before under the new name.
BioSig Technologies (NASDAQ:BSGM) ha annunciato un rebranding aziendale in Streamex Corp., con efficacia dal 12 settembre 2025, a seguito della recente fusione con Streamex Exchange Corporation. La società inizierà a negoziare con il nuovo ticker "STEX" sul mercato Nasdaq Capital Market.
Il rebranding riflette il modello di business ampliato e la strategia di crescita dell'azienda. Gli azionisti non devono intraprendere alcuna azione, poiché il numero CUSIP rimane invariato, e la struttura e le operazioni societarie proseguiranno come prima sotto il nuovo nome.
BioSig Technologies (NASDAQ:BSGM) anunció un cambio de marca corporativa a Streamex Corp., efectivo el 12 de septiembre de 2025, tras su reciente fusión con Streamex Exchange Corporation. La compañía empezará a cotizar bajo el nuevo símbolo "STEX" en el Nasdaq Capital Market.
El cambio de marca refleja el modelo de negocio ampliado y la estrategia de crecimiento de la empresa. Los accionistas no deben realizar ninguna acción, ya que el número CUSIP permanece sin cambios, y la estructura y las operaciones corporativas continuarán como antes bajo el nuevo nombre.
BioSig Technologies (NASDAQ:BSGM)는 Streamex Exchange Corporation과의 최근 합병을 계기로 2025년 9월 12일부로 사명 변경을 통해 Streamex Corp.로 리브랜딩한다고 발표했습니다. 회사는 Nasdaq Capital Market에서 새로운 티커 "STEX"로 거래를 시작합니다.
이번 리브랜딩은 확장된 비즈니스 모델과 성장 전략을 반영합니다. CUSIP 번호는 변경되지 않아 주주들이 별도로 조치를 취할 필요는 없으며, 법인 구조와 운영은 새 이름 아래 이전과 동일하게 계속됩니다.
BioSig Technologies (NASDAQ:BSGM) a annoncé un changement de nom commercial en Streamex Corp., effectif le 12 septembre 2025, suite à sa récente fusion avec Streamex Exchange Corporation. La société commencera à être cotée sous le nouveau symbole "STEX" sur le Nasdaq Capital Market.
Ce rebranding reflète l'élargissement du modèle d'affaires et la stratégie de croissance de l'entreprise. Les actionnaires n'ont aucune démarche à effectuer, car le numéro CUSIP reste inchangé, et la structure ainsi que les opérations de la société se poursuivront comme auparavant sous le nouveau nom.
BioSig Technologies (NASDAQ:BSGM) gab bekannt, dass das Unternehmen nach der jüngsten Fusion mit Streamex Exchange Corporation zum 12. September 2025 ein Firmenrebranding zu Streamex Corp. vornimmt. Das Unternehmen wird unter dem neuen Tickersymbol "STEX" am Nasdaq Capital Market gehandelt.
Das Rebranding spiegelt das erweiterte Geschäftsmodell und die Wachstumsstrategie des Unternehmens wider. Aktionäre müssen nichts unternehmen, da die CUSIP-Nummer unverändert bleibt, und die Unternehmensstruktur sowie die Geschäftstätigkeit unter dem neuen Namen wie bisher fortgeführt werden.
- None.
- None.
Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”.
LOS ANGELES & VANCOUVER, British Columbia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which recently merged with Streamex Exchange Corporation (“Streamex”) (together, “BSGM” or the “Company”), announced today that it will change its name to Streamex Corp., effective at 12:01 am Eastern Time on Friday, September 12, 2025. In connection with the name change, the Company will change its trading symbol to “STEX.” The Company’s common stock will commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol on September 12, 2025.
As of September 12, 2025, all Company stock trading, filings, and market related information will be reported under the new symbol “STEX”. The Company’s CUSIP number will remain unchanged, and no action is required from shareholders. No other aspects of the Company’s corporate structure or operations are impacted by the ticker symbol change.
About Streamex Exchange Corporation
Streamex is a Real World Asset (“RWA”) tokenization company with Institutional grade infrastructure to bring the gold and commodities market on chain. Enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.
About BioSig Technologies, Inc.
BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20250714401245/en/
Investor Relations Contact
Adele Carey
Alliance Advisors Investor Relations
acarey@allianceadvisors.com
Henry McPhie
CEO of BioSig, Co-Founder of Streamex
contact@Streamex.com
https://www.streamex.com/
https://x.com/streamex
Source: BioSig and Streamex
